-
1دورية أكاديمية
المؤلفون: Marco Massani, Tommaso Stecca
المصدر: Frontiers in Oncology, Vol 13 (2023)
مصطلحات موضوعية: pancreatic cancer, borderline resectable pancreatic cancer (BRPC), locally advanced pancreatic cancer (LAPC), Neoadjuvant chemo(radio)therapy, lymphnode metastasis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2023.1138587/fullTest; https://doaj.org/toc/2234-943XTest
-
2دورية أكاديمية
المؤلفون: Eva Versteijne, Ignace H. J. T. de Hingh, Marjolein Y. V. Homs, Martijn P. W. Intven, Joost M. Klaase, Hjalmar C. van Santvoort, Judith de Vos-Geelen, Johanna W. Wilmink, Geertjan van Tienhoven
المصدر: Frontiers in Oncology, Vol 11 (2022)
مصطلحات موضوعية: resectable pancreatic cancer (RPC), borderline resectable pancreatic cancer (BRPC), chemotherapy, radiotherapy, neoadjuvant treatment, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2021.744161/fullTest; https://doaj.org/toc/2234-943XTest
-
3دورية أكاديمية
المؤلفون: Versteijne, Eva, de Hingh, Ignace H.J.T., Homs, Marjolein Y.V., Intven, Martijn P.W., Klaase, Joost M., van Santvoort, Hjalmar C., de Vos-Geelen, Judith, Wilmink, Johanna W., van Tienhoven, Geertjan
المساهمون: MS Radiotherapie, Cancer
مصطلحات موضوعية: borderline resectable pancreatic cancer (BRPC), chemotherapy, neoadjuvant treatment, radiotherapy, resectable pancreatic cancer (RPC), Oncology, Cancer Research, Review, Journal Article
وصف الملف: application/pdf
-
4دورية أكاديمية
المؤلفون: Versteijne, E., de Hingh, I.H.J.T., Homs, M.Y.V., Intven, M.P.W., Klaase, J.M., van Santvoort, H.C., de Vos-Geelen, J., Wilmink, J.W., van Tienhoven, G.
المصدر: Versteijne , E , de Hingh , I H J T , Homs , M Y V , Intven , M P W , Klaase , J M , van Santvoort , H C , de Vos-Geelen , J , Wilmink , J W & van Tienhoven , G 2022 , ' Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy? ' , Frontiers in Oncology , vol. 11 , 744161 . https://doi.org/10.3389/fonc.2021.744161Test
مصطلحات موضوعية: resectable pancreatic cancer (RPC), borderline resectable pancreatic cancer (BRPC), chemotherapy, radiotherapy, neoadjuvant treatment, FULL-DOSE GEMCITABINE, ADJUVANT CHEMOTHERAPY, DUCTAL ADENOCARCINOMA, CONCURRENT RADIATION, UPFRONT SURGERY, OPEN-LABEL, THERAPY, MULTICENTER, CHEMORADIATION, RESECTION
العلاقة: https://cris.maastrichtuniversity.nl/en/publications/4eec92f0-e839-4041-b1ce-3a90411607deTest
الإتاحة: https://doi.org/10.3389/fonc.2021.744161Test
https://cris.maastrichtuniversity.nl/en/publications/4eec92f0-e839-4041-b1ce-3a90411607deTest -
5
المصدر: Frontiers in Oncology. 11
مصطلحات موضوعية: neoadjuvant treatment, RESECTION, borderline resectable pancreatic cancer (BRPC), MULTICENTER, DUCTAL ADENOCARCINOMA, CONCURRENT RADIATION, chemotherapy, OPEN-LABEL, UPFRONT SURGERY, THERAPY, CHEMORADIATION, ADJUVANT CHEMOTHERAPY, FULL-DOSE GEMCITABINE, resectable pancreatic cancer (RPC), radiotherapy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od________83::961f9d6cc3f5c0e07ebaa97ecd9eb906Test
https://cris.maastrichtuniversity.nl/en/publications/4eec92f0-e839-4041-b1ce-3a90411607deTest -
6
المؤلفون: Eva Versteijne, Ignace H. J. T. de Hingh, Marjolein Y. V. Homs, Martijn P. W. Intven, Joost M. Klaase, Hjalmar C. van Santvoort, Judith de Vos-Geelen, Johanna W. Wilmink, Geertjan van Tienhoven
المصدر: Versteijne, E, de Hingh, I H J T, Homs, M Y V, Intven, M P W, Klaase, J M, van Santvoort, H C, de Vos-Geelen, J, Wilmink, J W & van Tienhoven, G 2022, ' Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer : Chemotherapy or Chemoradiotherapy? ', Frontiers in Oncology, vol. 11, 744161 . https://doi.org/10.3389/fonc.2021.744161Test
Frontiers in Oncology, Vol 11 (2022)مصطلحات موضوعية: neoadjuvant treatment, Cancer Research, RESECTION, borderline resectable pancreatic cancer (BRPC), MULTICENTER, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, DUCTAL ADENOCARCINOMA, CONCURRENT RADIATION, OPEN-LABEL, chemotherapy, UPFRONT SURGERY, THERAPY, CHEMORADIATION, ADJUVANT CHEMOTHERAPY, Oncology, SDG 3 - Good Health and Well-being, FULL-DOSE GEMCITABINE, resectable pancreatic cancer (RPC), radiotherapy, RC254-282
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c06e03394ae7a131d9b7f1a35c92d636Test
https://research.vumc.nl/en/publications/dce31f4e-8e94-4ae5-ac0e-5c499bc28755Test